Abbvie Z Score
ABBV  Stock  USD 142.38 1.09 0.77% 
Abbvie  Z Score 
Abbvie Z Score Analysis
Abbvie's ZScore is a simple linear, multifactor model that measures the financial health and economic stability of a company. The score is used to predict the probability of a firm going into bankruptcy within next 24 months or two fiscal years from the day stated on the accounting statements used to calculate it. The model uses five fundamental business ratios that are weighted according to algorithm of Professor Edward Altman who developed it in the late 1960s at New York University..2019  2020  2021  2022 (projected)  
Receivables  5.43 B  8.82 B  9.98 B  10.76 B 
Inventories  1.81 B  3.31 B  3.13 B  3.37 B 
Z Score  =  Sum Of   5 Factors 
Current Abbvie Z Score  2.8 
Most of Abbvie's fundamental indicators, such as Z Score, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Abbvie Inc is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
 
 
 
 

Abbvie Z Score Driver Correlations
Understanding the fundamental principles of building solid financial models for Abbvie is extremely important. It helps to project a fair market value of Ford stock properly, considering its historical fundamentals such as Z Score. Since Abbvie's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Abbvie's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Abbvie's interrelated accounts and indicators.
Click cells to compare fundamentals
To calculate ZScore one would need to know current working capital of the company, its total assets, and liabilities, amount of latest retained earnings as well as earnings before interest and tax. ZScore can be used to compare the odds of bankruptcy of companies in a similar line of business or firms operating in the same industry. Companies with ZScores above 3.1 are generally considered to be stable and healthy with a low probability of bankruptcy. Scores that fall between 1.8 and 3.1 lie in a socalled 'grey area' with scores of less than 1, indicating the high probability of distress. Z Score is used widely by financial auditors, accountants, money managers, loan processers, wealth advisers, as well as day traders. In the last 25 years, many financial models that utilize z score has been proved to be successful as a predictor of corporate bankruptcy.
Compare to competition 
In accordance with the company's disclosures, Abbvie Inc has a Z Score of 2.8. This is 58.52% lower than that of the Healthcare sector and significantly higher than that of the Drug Manufacturersâ€”General industry. The z score for all United States stocks is 67.89% higher than that of the company.
Abbvie Z Score Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Abbvie's direct or indirect competition against its Z Score to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Abbvie could also be used in its relative valuation, which is a method of valuing Abbvie by comparing valuation metrics of similar companies.Abbvie is currently under evaluation in z score category among related companies.
Abbvie Current Valuation Drivers
We derive many important indicators used in calculating different scores of Abbvie from analyzing Abbvie's financial statements. These drivers represent accounts that assess Abbvie's ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of Abbvie's important valuation drivers and their relationship over time.
2017  2018  2019  2020  2021  2022 (projected)  
Net Income Per Employee  183.07 K  189.57 K  262.73 K  97.94 K  230.84 K  195.69 K  
Revenue Per Employee  972.97 K  1.09 M  1.11 M  971.89 K  1.12 M  970.16 K  
Average Assets  68.07 B  64.12 B  65.62 B  135.23 B  148.47 B  160.19 B  
Earnings Before Interest Taxes and Depreciation Amortization EBITDA  10.23 B  8.11 B  11.95 B  12.14 B  23.89 B  25.77 B  
Earnings Before Interest Taxes and Depreciation Amortization USD  10.23 B  8.11 B  11.95 B  12.14 B  23.89 B  25.77 B  
Earnings before Tax  7.73 B  5.2 B  8.43 B  3.39 B  12.98 B  10.48 B  
Average Equity  5.7 B  (2.8 B)  (8.2 B)  8.91 B  13.81 B  14.9 B  
Enterprise Value  183.74 B  171.17 B  158.69 B  268.34 B  307.91 B  261.19 B  
Free Cash Flow  9.43 B  12.79 B  12.77 B  16.79 B  21.99 B  23.73 B  
Invested Capital  38.87 B  38.24 B  66.08 B  83.51 B  69.94 B  59.64 B  
Invested Capital Average  41.72 B  38 B  44.01 B  81.18 B  77.72 B  62.54 B  
Market Capitalization  154.39 B  138.67 B  130.93 B  189.17 B  239.37 B  205.71 B  
Tangible Asset Value  27.44 B  22.46 B  54.86 B  34.56 B  38.2 B  35.35 B  
Working Capital  4.58 B  (294 M)  33.93 B  (4.49 B)  (7.27 B)  (7.46 B) 
Abbvie ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower socialengagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Abbvie's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Abbvie's managers, analysts, and investors.Environment Score  Governance Score  Social Score 
Abbvie Fundamentals
Return On Equity  86.59 %  
Return On Asset  8.22 %  
Profit Margin  22.03 %  
Operating Margin  51.39 %  
Current Valuation  319.7 B  
Shares Outstanding  1.77 B  
Shares Owned by Insiders  0.11 %  
Shares Owned by Institutions  71.44 %  
Number of Shares Shorted  14.03 M  
Price to Earning  33.98 X  
Price to Book  18.60 X  
Price to Sales  4.40 X  
Revenue  57.35 B  
Gross Profit  38.88 B  
EBITDA  29.47 B  
Net Income  12.56 B  
Cash and Equivalents  7.57 B  
Cash per Share  4.28 X  
Total Debt  73.65 B  
Debt to Equity  4.51 %  
Current Ratio  0.79 X  
Book Value Per Share  7.66 X  
Cash Flow from Operations  22.78 B  
Short Ratio  2.22 X  
Earnings Per Share  4.20 X  
Price to Earnings To Growth  63.35 X  
Number of Employees  50 K  
Beta  0.75  
Market Capitalization  252.1 B  
Total Asset  53.05 B  
Retained Earnings  4.32 B  
Working Capital  5.42 B  
Current Asset  16.31 B  
Current Liabilities  10.89 B  
Z Score  2.8  
Five Year Return  4.28 %  
Last Dividend Paid  5.64 
About Abbvie Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Abbvie Inc's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Abbvie using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Abbvie Inc based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company was incorporated in 2012 and is headquartered in North Chicago, Illinois. Abbvie operates under Drug ManufacturersGeneral classification in the United States and is traded on New York Stock Exchange. It employs 50000 people.
Be your own money manager
Our tools can tell you how much better you can do entering a position in Abbvie without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate riskadjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Fund Screener Now
Fund ScreenerFind activelytraded funds from around the world traded on over 30 global exchanges 
All Next  Launch Module 
Pair Trading with Abbvie
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Abbvie position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Abbvie will appreciate offsetting losses from the drop in the long position's value.The ability to find closely correlated positions to Abbvie could be a great tool in your taxloss harvesting strategies, allowing investors a quick way to find a similarenough asset to replace Abbvie when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Abbvie  that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Abbvie Inc to buy it.
The correlation of Abbvie is a statistical measure of how it moves in relation to other equities. This measure is expressed in what is known as the correlation coefficient, which ranges between 1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Abbvie moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Abbvie Inc moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Abbvie can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better riskadjusted return on your portfolios.Please continue to Abbvie Piotroski F Score and Abbvie Valuation analysis. Note that the Abbvie Inc information on this page should be used as a complementary analysis to other Abbvie's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Idea Optimizer module to use advanced portfolio builder with precomputed micro ideas to build optimal portfolio .
Complementary Tools for Abbvie Stock analysis
When running Abbvie Inc price analysis, check to measure Abbvie's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Abbvie is operating at the current time. Most of Abbvie's value examination focuses on studying past and present price action to predict the probability of Abbvie's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Abbvie's price. Additionally, you may evaluate how the addition of Abbvie to your portfolios can decrease your overall portfolio volatility.
Equity ValuationCheck real value of public entities based on technical and fundamental data  Go  
Equity AnalysisResearch over 250,000 global equities including funds, stocks and ETFs to find investment opportunities  Go  
Piotroski F ScoreGet Piotroski F Score based on binary analysis strategy of nine different fundamentals  Go  
Idea BreakdownAnalyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sectorfocused investing themes  Go  
Crypto CorrelationsUse cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins  Go  
Competition AnalyzerAnalyze and compare many basic indicators for a group of related or unrelated entities  Go  
Companies DirectoryEvaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals  Go  
Fundamentals ComparisonCompare fundamentals across multiple equities to find investing opportunities  Go 
Is Abbvie's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Abbvie. If investors know Abbvie will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Abbvie listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth YOY 0.21  Market Capitalization 251.5 B  Quarterly Revenue Growth YOY 0.045  Return On Assets 0.0814  Return On Equity 0.93 
The market value of Abbvie Inc is measured differently than its book value, which is the value of Abbvie that is recorded on the company's balance sheet. Investors also form their own opinion of Abbvie's value that differs from its market value or its book value, called intrinsic value, which is Abbvie's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Abbvie's market value can be influenced by many factors that don't directly affect Abbvie's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Abbvie's value and its price as these two are different measures arrived at by different means. Investors typically determine Abbvie value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Abbvie's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.